These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 344230)

  • 1. Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes.
    König W; Czarnetzki BM; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(4):364-75. PubMed ID: 344230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM; König W; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W; Czarnetzki BM; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W; Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1978; 57(5):399-410. PubMed ID: 352966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W; Tesch H; Frickhofen N
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuli.
    Tesch H; König W
    Scand J Immunol; 1980; 11(4):409-18. PubMed ID: 6770461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.
    Czarneztki BM
    Chem Phys Lipids; 1982 Oct; 31(2):205-11. PubMed ID: 6814773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the eosinophil chemotactic factor (ECF) release from various cells and their subcellular components by phospholipids.
    König W; Kroegel C; Pfeiffer P; Tesch H
    Int Arch Allergy Appl Immunol; 1981; 65(4):417-31. PubMed ID: 6788714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils.
    Sánchez-Crespo M; Alonso F; Egido J
    Immunology; 1980 Aug; 40(4):645-55. PubMed ID: 6776037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W; Frickhofen N; Tesch H
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes.
    Czarnetzki BM
    Scand J Immunol; 1981; 13(6):511-6. PubMed ID: 6797047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils.
    Raible DG; Schulman ES; DiMuzio J; Cardillo R; Post TJ
    J Immunol; 1992 Jun; 148(11):3536-42. PubMed ID: 1588043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).
    Frickhofen N; König W
    Immunology; 1979 May; 37(1):111-22. PubMed ID: 468298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid.
    Tesch H; König W; Frickhofen N
    Int Arch Allergy Appl Immunol; 1979; 58(4):436-46. PubMed ID: 35469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes.
    König W; Czarnetzki BM; Lichtenstein LM
    Monogr Allergy; 1977; 12():198-212. PubMed ID: 335215
    [No Abstract]   [Full Text] [Related]  

  • 20. Mediator release from basophil granulocytes in chronic myelogenous leukemia.
    Clark RA; Gallin JI; Kaplan AP
    J Allergy Clin Immunol; 1976 Dec; 58(6):623-34. PubMed ID: 62774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.